Concepedia

H. Pöhlmann

HP

Statistics

Publications

17

Citations

1.8K

H-Index

15

Active since

1988

Affiliations

Novartis (Switzerland)(Current)

University Hospital of Basel

Ludwig-Maximilians-Universität München

Université de Lille

Novartis (Sweden)

H. Pöhlmann is an author at Novartis (Switzerland) specializing in medicine, neurology, and neuropharmacology.

Top concepts

Publications per year

1988–2021

17

Publications

17

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

Marilisa M. Guerreiro, Ulf Vigonius, H. Pöhlmann et al. · Epilepsy Research · 1997 · 241 citations

, , +4

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Krzysztof Selmaj, David K.B. Li, Hans-Peter Hartung et al. · The Lancet Neurology · 2013 · 230 citations

, , +7

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

W. Christe, Günter Krämer, Ulf Vigonius et al. · Epilepsy Research · 1997 · 217 citations

, , +3

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

Pierre Alfred Bill, Ulf Vigonius, H. Pöhlmann et al. · Epilepsy Research · 1997 · 215 citations

, , +4

Oral fingolimod (FTY720) in multiple sclerosis

Paul O’Connor, Giancarlo Comi, Xavier Montalbán et al. · Neurology · 2009 · 190 citations

Rows per page

1–5 of 17